ST ANDREW'S DAY PAEDIATRIC SYMPOSIUM Friday 25th November 2022 Royal College of Physicians and Surgeons of Glasgow.

Abstract

Background: High-fl ow nasal cannula oxygen (HFNCO) therapy is a well-recognised therapy to provide respiratory support to infants with bronchiolitis. It has been provided on the general paediatric receiving ward in the Royal Hospital for Children (RHC), Glasgow for 3 years, having previously been delivered only in Paediatric Intensive Care Unit (PICU). Due to COVID-19 the requirement for PICUsto have a contingency plan to increase critical care capacity and initiate changes in critical care practice high-lighted the importance of providing ward-based HFNC. Aims: To ascertain the effectiveness and safety of using HFNC within the ward setting and establish the number of PICU days saved. Methodology: